167 related articles for article (PubMed ID: 22624541)
21. Pragmatism and virtue ethics in clinical research.
Goldberg D
Am J Bioeth; 2008 Apr; 8(4):43-5. PubMed ID: 18576255
[No Abstract] [Full Text] [Related]
22. [Clinical drug trials].
Schulte-Wissermann H
Kinderkrankenschwester; 2013 Jun; 32(6):210. PubMed ID: 23822049
[No Abstract] [Full Text] [Related]
23. [Take-over of the risk-benefit by the clinical study subject and its regulation].
Antal J
Orv Hetil; 2005 Jun; 146(26):1399-404. PubMed ID: 16052982
[TBL] [Abstract][Full Text] [Related]
24. Is there a case for a distinction between ethics and policy?
Hunter D
Am J Bioeth; 2010 Jun; 10(6):24-5. PubMed ID: 20526965
[No Abstract] [Full Text] [Related]
25. Extend the reach of institutional review boards first, then strengthen their depth.
Spike J
Am J Bioeth; 2008 Nov; 8(11):11-2. PubMed ID: 19061097
[No Abstract] [Full Text] [Related]
26. [Ethics symposium. 2-3 April 2007, Paris, France. Foreword].
Ahouanto M
Bull Soc Pathol Exot; 2008 Apr; 101(2):75-6. PubMed ID: 18543696
[No Abstract] [Full Text] [Related]
27. Toward effective Canadian public-private partnerships in health research.
Bernstein A
CMAJ; 2003 Feb; 168(3):288-9. PubMed ID: 12566334
[No Abstract] [Full Text] [Related]
28. Fair benefits in international medical research.
Arras JD
Hastings Cent Rep; 2004; 34(3):3. PubMed ID: 15281717
[No Abstract] [Full Text] [Related]
29. Research ethics and law of healthcare system quality improvement: the conflict of cost containment and quality.
Kofke WA; Rie MA
Crit Care Med; 2003 Mar; 31(3 Suppl):S143-52. PubMed ID: 12626960
[TBL] [Abstract][Full Text] [Related]
30. Deprivation, disease, and the ethics of international research.
London A
Bioeth Exam; 2000; 4(1):1, 4. PubMed ID: 14746326
[No Abstract] [Full Text] [Related]
31. [Research ethics guidelines: partly different requirements in various types of trials].
Nilstun T; Löfmark R
Lakartidningen; 2005 Oct 10-16; 102(41):2932-4, 2937. PubMed ID: 16294510
[No Abstract] [Full Text] [Related]
32. Making pragmatism practicable for the institutional review board.
Robertson C
Am J Bioeth; 2008 Apr; 8(4):49-51. PubMed ID: 18576258
[No Abstract] [Full Text] [Related]
33. Why adopt a maximin theory of exploitation?
Wertheimer A; Millum J; Schaefer GO
Am J Bioeth; 2010 Jun; 10(6):38-9. PubMed ID: 20526968
[No Abstract] [Full Text] [Related]
34. In defense of valid design as a policy rule.
Evans EL
Am J Bioeth; 2010 Jun; 10(6):18-9. PubMed ID: 20526962
[No Abstract] [Full Text] [Related]
35. Evaluating benefits and harms in intensive care research.
Weijer C; Miller PB
Intensive Care Med; 2007 Oct; 33(10):1819-22. PubMed ID: 17690865
[No Abstract] [Full Text] [Related]
36. Enrolling the uninsured in clinical trials: an ethical perspective.
Pace C; Miller FG; Danis M
Crit Care Med; 2003 Mar; 31(3 Suppl):S121-5. PubMed ID: 12626956
[TBL] [Abstract][Full Text] [Related]
37. Human subject protection: overkill?
Kim PJ
J Foot Ankle Surg; 2010; 49(4):317-8. PubMed ID: 20537567
[No Abstract] [Full Text] [Related]
38. Use of healthy children as volunteers in drug studies: the ethical debate.
Koren G; Kearns GL; Reed M; Pons G
Clin Pharmacol Ther; 2003 Mar; 73(3):147-52. PubMed ID: 12621379
[No Abstract] [Full Text] [Related]
39. Undue inducements and reasonable risks: will the dismal science lead to dismal research ethics?
London AJ
Am J Bioeth; 2005; 5(5):29-32. PubMed ID: 16179305
[No Abstract] [Full Text] [Related]
40. Not just how, but whether: revisiting Hans Jonas.
Wolpe PR
Am J Bioeth; 2003; 3(4):vii-viii. PubMed ID: 14744305
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
